Matches in Nanopublications for { ?s ?p "[In PKD2, median age to hypertension treatment was 51 yr, to CKD stage 3 was 66 yr, to death was 71 yr, and ESRD was infrequent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- NP627013.RADu8yuAjoWHd1pOqkABYdAFXbkrpZCYWvN0EeqbtoDtA130_assertion description "[In PKD2, median age to hypertension treatment was 51 yr, to CKD stage 3 was 66 yr, to death was 71 yr, and ESRD was infrequent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627013.RADu8yuAjoWHd1pOqkABYdAFXbkrpZCYWvN0EeqbtoDtA130_provenance.
- NP626903.RA_Y4kGWVIf3aZwDVU394p-3BDOSggofpS5enosBqzYKc130_assertion description "[In PKD2, median age to hypertension treatment was 51 yr, to CKD stage 3 was 66 yr, to death was 71 yr, and ESRD was infrequent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP626903.RA_Y4kGWVIf3aZwDVU394p-3BDOSggofpS5enosBqzYKc130_provenance.
- NP879534.RAym90S7PPQV_TKgae-comsBBSyY8MVHBgRwfrxdlLufc130_assertion description "[In PKD2, median age to hypertension treatment was 51 yr, to CKD stage 3 was 66 yr, to death was 71 yr, and ESRD was infrequent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879534.RAym90S7PPQV_TKgae-comsBBSyY8MVHBgRwfrxdlLufc130_provenance.
- NP625123.RA_EaqToOvTMLmHxiWA12gO4LeiX_nX99IRQLizPKsEns130_assertion description "[In PKD2, median age to hypertension treatment was 51 yr, to CKD stage 3 was 66 yr, to death was 71 yr, and ESRD was infrequent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625123.RA_EaqToOvTMLmHxiWA12gO4LeiX_nX99IRQLizPKsEns130_provenance.
- NP625129.RAWZBhs05ykgvdYwvPy1xlYpSbthur13JMZkB5wtIB_xE130_assertion description "[In PKD2, median age to hypertension treatment was 51 yr, to CKD stage 3 was 66 yr, to death was 71 yr, and ESRD was infrequent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625129.RAWZBhs05ykgvdYwvPy1xlYpSbthur13JMZkB5wtIB_xE130_provenance.
- assertion description "[In PKD2, median age to hypertension treatment was 51 yr, to CKD stage 3 was 66 yr, to death was 71 yr, and ESRD was infrequent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In PKD2, median age to hypertension treatment was 51 yr, to CKD stage 3 was 66 yr, to death was 71 yr, and ESRD was infrequent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP879435.RAjpsTQYywkjH1EzFo_X93BSCjxRkQDGqo0ROO6RiVv5Q130_assertion description "[In PKD2, median age to hypertension treatment was 51 yr, to CKD stage 3 was 66 yr, to death was 71 yr, and ESRD was infrequent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP879435.RAjpsTQYywkjH1EzFo_X93BSCjxRkQDGqo0ROO6RiVv5Q130_provenance.
- NP625119.RAHXKqAfY5Vt1zRN_6qLARD5YKGVkTXbOnEc5HrikXsl0130_assertion description "[In PKD2, median age to hypertension treatment was 51 yr, to CKD stage 3 was 66 yr, to death was 71 yr, and ESRD was infrequent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625119.RAHXKqAfY5Vt1zRN_6qLARD5YKGVkTXbOnEc5HrikXsl0130_provenance.
- NP625120.RAi0a4XSdDkTa7llo1EWcq_VLrPOLmIJWKWAC_Gzpe4Ns130_assertion description "[In PKD2, median age to hypertension treatment was 51 yr, to CKD stage 3 was 66 yr, to death was 71 yr, and ESRD was infrequent.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625120.RAi0a4XSdDkTa7llo1EWcq_VLrPOLmIJWKWAC_Gzpe4Ns130_provenance.